Founded Year

2013

Stage

Incubator/Accelerator - IV | Alive

Total Raised

$26.79M

About Sensely

Sensely uses natural user interfaces to intelligently connect insurance and health plan members with advice and services. Sensely’s avatar and chatbot-based platforms assist insurance plan members and patients with the insurance services and healthcare resources they need, when they need it.

Sensely Headquarter Location

1871 26th Ave

San Francisco, California, 94122,

United States

415-290-3872

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Sensely's Products & Differentiation

See Sensely's products and how their products differentiate from alternatives and competitors

  • Symptom Checker

    An easy to use conversational application that asks the user a short series of questions, and then makes a recommendation for what the user should do next.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

  • Subscribe to see more

    We're on a mission to enable every organization to make smarter decisions about tech. Whether it's finding a new game-changing vendor or understanding a new market, it's easier, faster and smarter with CB Insights. All made possible by the smartest, hardest-working team in tech. Subscribe to see more.

Expert Collections containing Sensely

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sensely is included in 8 Expert Collections, including Conference Exhibitors.

C

Conference Exhibitors

5,501 items

HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare

I

Insurtech

2,352 items

Companies and startups that use of technology to improve core and ancillary insurance operations. Companies in this collection are creating new product architectures, improving underwriting models, accelerating claims and creating a better customer experience

A

Artificial Intelligence

9,093 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

M

Medical Devices

8,452 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

10,772 items

Companies partnering with healthcare stakeholders to improve operational efficiency across payment, supply chain, data mgmt, and more.

F

Fintech

7,442 items

US-based companies

Latest Sensely News

Artificial Intelligence (AI) in Life Sciences Market Size to Worth US$ 6.7 Bn by 2030

Jun 22, 2022

Key Players IBM Corporation, Atomwise, Inc., Nuance Communications, Inc., NuMedii, Inc., AiCure LLC., APIXIO, Inc., Insilico Medicine, Inc., Enlitic, Inc., Sensely, Inc., Zebra Medical Vision Regional Snapshot North America led the global AI in life sciences market. US was the major driver of the North America AI in life sciences market in 2021. The US is known to be the home of the several leading biotech and pharma companies that are the major investors in the research and development, drug discovery, and clinical trial activities. The increased demand for the AI technology among the research organizations and the pharmaceutical companies has led to the dominance of North America in the AI in life sciences market. Approximately US$80 billion was invested on research and development by the pharmaceutical companies in 2018 across the globe, as per the data of Pharmaceutical Research and Manufacturers of America (PhRMA). US leads the globe in terms of new drug discovery and development and it holds the property rights of the majority of the drugs that has been recently developed. Asia Pacific is the home to several top research organizations that are the major drivers of the AI in life sciences market in Asia Pacific. The presence of top research institutions and rising investments in the research studies of various diseases and its treatment has bolstered the demand for the AI hardware and software in Asia Pacific region. The growing government investments towards advancing the medical infrastructure and rising pharma FDIs in the region is expected to boost the growth of the market in the forthcoming years. Market Dynamics Growing need for clinical trials and drug discovery Drug discovery and clinical trials are expensive affairs that involve huge recurring costs. The research, development, candidate recruitment, candidate retention, and various phases of clinical trials, each of them are very costly and the low success rate of these activities increases the costs for the company at a significant level. As per the Pharmaceutical Research and Manufacturers of America (PhRMA), the pharma companies spends around 19 % of their revenue, on an average, in the research. Therefore, the growing the growing need for controlling costs and improving outcomes is boosting the adoption of AI in life sciences field. Restraints Huge capital investments The artificial intelligence is an expensive and latest technology that has gained a rapid traction across the globe and across various industry verticals. The rising need for data analytics, deep learning, machine learning, and natural language processing are the major drivers of the AI technology. However, the high capital investments in the deployment of AI in the life sciences companies may hinder the market growth during the forecast period. Opportunity Lack of AI experts AI is a new technology and there is a dearth of experts and skilled staffs that can efficiently handle the AI based software and hardware systems. This automatically increases the third party services provided by the AI in life sciences market players, which increases the revenues of the AI in life sciences market players. This factor is offering the market players to generate huge revenues on recurring basis. Challenge Data privacy and cybersecurity With the growing adoption of the digital technologies, the risks of malware and cyberattacks has significantly increased across the globe. The growing number of cyberattacks and rising concerns regarding the data privacy is the major challenge for the market players. Related Reports Immediate Delivery Available | Buy this Premium Research Report@ https://www.precedenceresearch.com/checkout/1776 You can place an order or ask any questions, please feel free to contact at  sales@precedenceresearch.com   | +1 9197 992 333 About Us Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. For Latest Update Follow Us:

Sensely Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Sensely Rank

  • When was Sensely founded?

    Sensely was founded in 2013.

  • Where is Sensely's headquarters?

    Sensely's headquarters is located at 1871 26th Ave, San Francisco.

  • What is Sensely's latest funding round?

    Sensely's latest funding round is Incubator/Accelerator - IV.

  • How much did Sensely raise?

    Sensely raised a total of $26.79M.

  • Who are the investors of Sensely?

    Investors of Sensely include InsurTech NY, Plug and Play Japan, Pegasus Tech Ventures, Chengwei Capital, Susquehanna International Group and 18 more.

  • Who are Sensely's competitors?

    Competitors of Sensely include App Orchid, Qumata, Ada Health, Babylon Health, Mediktor and 8 more.

  • What products does Sensely offer?

    Sensely's products include Symptom Checker and 3 more.

  • Who are Sensely's customers?

    Customers of Sensely include AXA, Allianz and Nippon.

You May Also Like

App Orchid Logo
App Orchid

The App Orchid platform helps enterprises build AI-fueled apps for the energy, utilities, insurance, and healthcare industries. ContractAI is a product built on App Orchid's AI platform to transform the contracting process - improving the analysis, creation, and negotiation of contracts. ContractAI utilizes AI to automatically ingest and analyze historical contracts to author templates based on terms that were proven win-win. The company was founded in 2013 and is based in San Ramon, California.

ForMotiv Logo
ForMotiv

ForMotiv is an end-to-end platform for reducing online risk and improving customer experience that measures end-user behavioral biometrics in real-time to detect future outcomes like fraud, delinquency, profitability, and abandonment as users engage with digital applications.

Indico Data Logo
Indico Data

Indico Data is a company that develops a process automation platform to accelerate document-based workflows. The company offers solutions such as RPA, intelligent document processing, and more. The company was founded in 2013 and is based in Boston, Massachusetts.

T
Traffk

Traffk offers a SaaS platform that enables an organization to deploy data mining, analytics and rules automation to manage risk, pricing and utilization. The company aims to modernize the insurance underwriting process with more accurate data insights and risk profiling that allows risk-bearing companies or health plans to manage profitability, risk, market growth, cross-lines sales, marketing and compliance.

P
Praktice.ai

Praktice offers healthcare analytics that helps drive revenues and improves margins for hospitals and health organizations through critical insights.

Qumata Logo
Qumata

Qumata offers a convenient alternative to lengthy questionnaires and doctor's visits. Customers simply need to share their digital data so that Qumata's algorithm can calculate an accurate and individualized medical risk profile.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.